跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nasehaler - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nasehaler
Approved
STANDARD
Nasehaler
Cipla Limited, Indore Sez (Unit III)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5c0be08e17d81b05
Company
Cipla Limited, Indore Sez (Unit III)
Type
Standard
Approval Details
Approval Id
5c0be08e17d81b05
Drug Approval Philippines Name
Nasehaler
Product Name
Nasehaler
Registration Number
DRP-13925
Brand Name
Nasehaler
Generic Name
Mometasone furoate (as monohydrate)
Dosage Form
Nasal Spray Suspension
Dosage Strength
50 mcg per actuation (0.05% w/w)
Manufacturer
Cipla Limited, Indore Sez (Unit III)
Importer
RV Group Phil. Branch
Distributor
RV Group Phil. Branch
Issuance Date
27 May 2024
Expiry Date
18 May 2028
Pharmacologic Category
Corticosteroid
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5c0be08e17d81b05
Type
Standard
Back to Philippines FDA Approvals